Charles River Associates (CRAI)
(Delayed Data from NSDQ)
$168.27 USD
-8.22 (-4.66%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $168.26 -0.01 (-0.01%) 7:26 PM ET
2-Buy of 5 2
B Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$168.27 USD
-8.22 (-4.66%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $168.26 -0.01 (-0.01%) 7:26 PM ET
2-Buy of 5 2
B Value A Growth D Momentum B VGM
Zacks News
Xerox (XRX) to Transition Peru and Ecuador Operations to PBS
by Zacks Equity Research
Xerox's (XRX) staff in Peru and Ecuador will transition to PBS, which will then serve as the exclusive distribution partner for Xerox in these regions.
Is Charles River Associates (CRAI) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how CRA International (CRAI) and Healthcare Services (HCSG) have performed compared to their sector so far this year.
Looking for a Growth Stock? 3 Reasons Why CRA (CRAI) is a Solid Choice
by Zacks Equity Research
CRA (CRAI) possesses solid growth attributes, which could help it handily outperform the market.
IQVIA (IQV) Appreciates 24% in a Year: Here's What to Know
by Zacks Equity Research
IQVIA's (IQV) combined offerings of research and development and commercial services are helping it to develop trusted relationships.
Reasons to Retain Affirm (AFRM) Stock in Your Portfolio
by Zacks Equity Research
Affirm (AFRM) is poised for growth in the long term, driven by improved gross merchandise value, active merchants and transactions.
Growth Strategies Aid Waste Management (WM) Amid Competition
by Zacks Equity Research
Waste Management (WM) is benefiting from its focus on differentiation and continuous improvement amid competition and financing costs.
Mastercard (MA) Unveils Two Credit Cards Infused With Rewards
by Zacks Equity Research
Mastercard (MA) collaborates with Emirates NBD and Marriott Bonvoy to introduce co-branded credit cards and enable Cardholders to enjoy exclusive hotel stay benefits with the accumulated card spending points.
Charles River's (CRAI) Diversification Fuels Growth Globally
by Zacks Equity Research
Charles River's (CRAI) global network of coordinated offices and a diversified business mix drive growth and adaptability.
CRAI or IT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRAI vs. IT: Which Stock Is the Better Value Option?
Should Value Investors Buy Charles River Associates (CRAI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Reasons to Retain Charles River (CRAI) in Your Portfolio Now
by Zacks Equity Research
Commitment to shareholder returns makes Charles River (CRAI) a reliable way for investors to compound wealth over the long term.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CRA International (CRAI) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CRA International (CRAI) Shares Up 5% Post Q4 Earnings Beat
by Zacks Equity Research
CRA International's (CRAI) fourth-quarter 2023 earnings and revenues grow year over year.
CRA International (CRAI) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CRA (CRAI) delivered earnings and revenue surprises of 48.18% and 8.10%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
CRA International (CRAI) to Post Q4 Earnings: What to Expect?
by Zacks Equity Research
CRA International's (CRAI) fourth-quarter 2023 revenues are likely to have benefitted from improved Forensic Services and Life Sciences performances.
FTI Consulting (FCN) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
FTI Consulting (FCN) delivered earnings and revenue surprises of 45.22% and 11.51%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Charles River (CRAI) Stock Rises 6.4% in a Month: Here's How
by Zacks Equity Research
Commitment to shareholder returns makes Charles River (CRAI) a reliable way for investors to compound wealth over the long term.
Strong Liquidity Aids Charles River (CRAI) Amid Cost Woes
by Zacks Equity Research
Charles River (CRAI) has been consistently returning value to its shareholders in the form of dividends and share purchases.
New Strong Sell Stocks for November 22nd
by Zacks Equity Research
ASTE, CRAI and JBLU have been added to the Zacks Rank #5 (Strong Sell) List on November 22, 2023.
Charles River (CRAI) Stock Surges Despite Q3 Earnings Miss
by Zacks Equity Research
Charles River's (CRAI) third-quarter 2023 earnings and revenues decline year over year.
Down -15.37% in 4 Weeks, Here's Why CRA (CRAI) Looks Ripe for a Turnaround
by Zacks Equity Research
CRA (CRAI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks.com featured highlights G-III Apparel, JAKKS Pacific, Titan Machinery, Charles River and KB Home
by Zacks Equity Research
G-III Apparel, JAKKS Pacific, Titan Machinery, Charles River and KB Home have been highlighted in this Screen of The Week article.
Earnings Preview: CRA International (CRAI) Q3 Earnings Expected to Decline
by Zacks Equity Research
CRA (CRAI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.